Skip to main content

Saturday, July 20:  All UR Medicine facilities are open as scheduled and providing safe patient care, with a goal to return all clinical services to full efficiency by early next week.
Patients: click here for more information. Faculty/Staff: click here for information.


  • Bajaj Research Photo 1
  • Bajaj Research Photo 2

Bajaj Lab

Welcome to the Bajaj Lab


Poorly differentiated aggressive myeloid diseases are often resistant to standard therapy and associated with significantly poor survival in both children and adults. There is thus a significant need for a better understanding of the mechanisms that drive disease progression and for finding novel therapeutic targets. While intrinsic signals that drive myeloid cancer progression are well described, little is known about how interactions with the surrounding microenvironment can control leukemic growth and propagation. The primary goal of the Bajaj lab is to define the role of cancer stem cell interactions with their microenvironment in disease progression. To address these questions, we use genetic mouse models of human disease and primary human patient samples, CRISPR screening, as well as real time imaging techniques. In the long term, these studies will not only add to our understanding of the niche in the development and progression of hematological malignancies, but may also contribute to the design of novel therapies.

Jeevisha Bajaj, Ph.D.

Jeevisha Bajaj, Ph.D.
Principal Investigator

Selected Publications

Bajaj J§, Hamilton M, Shima Y, Chambers K, Spinler K, Van Nostrand E, Yee B, Blue S, Chen M, Rizzeri D, Chuah C, Oehler V, Broome E, Sasik R, Scott-Browne J, Rao A, Yeo G and Reya T§ (2020). "An In Vivo Genome-Wide CRISPR Screen Identifies the RNA-Binding Protein Staufen2 as a Key Regulator of Myeloid Leukemia.” Nature Cancer (DOI:10.1038/s43018-020-0054-2)

§ Co-corresponding

Bajaj J*, Konuma T*, Lytle NK, Kwon HY, Ablack JN, Cantor JM, Rizzieri D, Chuah C, Oehler VG, ​Broome EH, ​Ball ED, ​van der Horst EH, ​Ginsberg MH, ​Reya T. CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.; Cancer cell; Vol 30(5). 2016 Nov 14. ​​

Fox RG, ​Lytle NK, ​Jaquish DV, ​Park FD, ​Ito T, ​Bajaj J, ​Koechlein CS, ​Zimdahl B, ​Yano M, ​Kopp J, ​Kritzik M, ​Sicklick J, ​Sander M, ​Grandgenett PM, ​Hollingsworth MA, ​Shibata S, ​Pizzo D, ​Valasek M, ​Sasik R, ​Scadeng M, ​Okano H, ​Kim Y, ​MacLeod AR, ​Lowy AM, ​Reya T. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.; Nature; Vol 534(7607). 2016 Jun 16.

Kwon HY*, ​Bajaj J*, ​Ito T, ​Blevins A, ​Konuma T, ​Weeks J, ​Lytle NK, ​Koechlein CS, ​Rizzieri D, ​Chuah C, ​Oehler VG, ​Sasik R, ​Hardiman G, ​Reya T. Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.; Cell stem cell; Vol 17(2). 2015 Aug 06.​

*Equal contribution

View All Publications

Contact Us

  Bajaj Lab
601 Elmwood Ave
Rochester, NY 14642